Adoptive immunotherapy of cancer with activated lymph node cells primed in vivo with autologous tumor cells transduced with the GM-CSF gene.
Chang
A E
AE
University of Michigan, Ann Arbor, MI, USA.
Sondak
V K
VK
Bishop
D K
DK
Nickoloff
B J
BJ
Mulligan
R C
RC
Mulé
J J
JJ
D000818:Animals; D000911:Antibodies, Monoclonal / Q000276:immunology; D019496:Cancer Vaccines / Q000008:administration & dosage / Q000235:genetics / Q000276:immunology; D002985:Clinical Protocols; D005240:Feasibility Studies; D018014:Gene Transfer Techniques; D005822:Genetic Vectors; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000235:genetics* / Q000378:metabolism; D006801:Humans; D016219:Immunotherapy, Adoptive; D007376:Interleukin-2 / Q000008:administration & dosage; D007680:Kidney Neoplasms / Q000235:genetics / Q000276:immunology / Q000628:therapy*; D008198:Lymph Nodes / Q000166:cytology*; D008213:Lymphocyte Activation; D008545:Melanoma / Q000235:genetics / Q000276:immunology / Q000628:therapy*; D008979:Moloney murine leukemia virus / Q000235:genetics; D013601:T-Lymphocytes / Q000276:immunology / Q000637:transplantation*; D014407:Tumor Cells, Cultured / Q000276:immunology
D000911:Antibodies, Monoclonal; D019496:Cancer Vaccines; D007376:Interleukin-2; D016178:Granulocyte-Macrophage Colony-Stimulating Factor